Followers | 43 |
Posts | 5107 |
Boards Moderated | 1 |
Alias Born | 12/19/2002 |
Thursday, September 09, 2021 10:22:55 AM
thanks,
ND9
Item 8.01 Other Information.
The Company disclosed that on August 23, 2021, Jay Bray, Chairman and Chief Executive Officer, entered into a pre-arranged stock trading plan (the “10b5-1 Plan”) with a brokerage firm to sell up to a maximum of 120,000 shares of the Company’s common stock (“Common Stock”) between September 23, 2021 and September 23, 2022 in order to diversify his investment holdings. The maximum number of shares that could be sold over the twelve-month period represents approximately 10% of Mr. Bray’s current ownership of Common Stock.
The 10b5-1 Plan was designed to comply with the Company’s insider trading policies and the guidelines specified in Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended, which permit an officer or director to enter into a pre-arranged plan for buying or selling Company stock at a time when the officer or director is not in possession of material, nonpublic information about the Company. All sales of Common Stock under the 10b5-1 Plan will be disclosed publicly in accordance with applicable securities laws, rules, and regulations through appropriate filings with the U.S. Securities and Exchange Commission.
Recent COOP News
- Mr. Cooper Group Reports First Quarter 2024 Results • Business Wire • 04/24/2024 11:00:00 AM
- Mr. Cooper Group Announces Two New Senior Leaders • Business Wire • 04/23/2024 01:00:00 PM
- Mr. Cooper Group Inc. to Discuss First Quarter 2024 Financial Results on April 24, 2024 • Business Wire • 04/05/2024 03:37:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:34:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:04:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:03:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 11:01:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:59:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 09:28:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:15:59 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:13:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 12:00:29 PM
- Mr. Cooper Group Reports Fourth Quarter 2023 Results • Business Wire • 02/09/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 09:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:26:40 PM
- Mr. Cooper Group Inc. Announces Pricing of Offering of $1 Billion of Senior Notes • Business Wire • 01/29/2024 11:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 12:55:56 PM
- Mr. Cooper Group Inc. to Discuss Fourth Quarter 2023 Financial Results on February 9, 2024 • Business Wire • 01/11/2024 09:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 09:00:53 PM
- Mr. Cooper Group Appoints Mike Weinbach as President • Business Wire • 01/09/2024 09:00:00 PM
- Meta CEO Sells $428 Million in Shares Since November, AMC Hits New Record Low, and More • IH Market News • 01/04/2024 09:51:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:19:20 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/29/2023 08:45:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:08:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM